Journal Pre-proof Medicinal plants: Treasure trove for green synthesis of metallic nanoparticles and their biomedical applications Harish Chandra, Pragati Kumari, Elza Bontempi, Saurabh Yadav PII:
S1878-8181(19)31299-X
DOI:
https://doi.org/10.1016/j.bcab.2020.101518
Reference:
BCAB 101518
To appear in:
Biocatalysis and Agricultural Biotechnology
Received Date: 4 September 2019 Revised Date:
6 January 2020
Accepted Date: 28 January 2020
Please cite this article as: Chandra, H., Kumari, P., Bontempi, E., Yadav, S., Medicinal plants: Treasure trove for green synthesis of metallic nanoparticles and their biomedical applications, Biocatalysis and Agricultural Biotechnology (2020), doi: https://doi.org/10.1016/j.bcab.2020.101518. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier Ltd.
1
Medicinal Plants : Treasure Trove for Green Synthesis of Metallic Nanoparticles and their
2
biomedical applications
3
4
Harish Chandra1, ¥, Pragati Kumari2,¥*, Elza Bontempi3, Saurabh Yadav4*
5 6
1
7
249404, India
Department of Botany and Microbiology, Gurukula Kangri Vishwavidayalaya, Haridwar
8 9
2
Scientist Hostel-S-02, Chauras campus, Srinagar Garhwal, Uttarakhand, 246174, India
10
3
INSTM and Mechanical and Industrial Engineering Department, University of Brescia, Via
11
Branze 38, 25123, Brescia, Italy.
12
4
13
Srinagar Garhwal, Uttarakhand, 246174, India
14
*Corresponding author, ¥ Contributed equally
Department of Biotechnology, Hemvati Nandan Bahuguna Garhwal (Central) University,
15
16
17
18
19
20
1
21
Abstract
22
The cornerstone of nanoscience and nanotechnology are nanoparticles which have immense
23
power and functional ability in diverse fields. Nanoparticles are synthesized by physical,
24
chemical methos but limitations are due to its toxicity. We have discussed few green synthesis
25
routes which are eco friendly and less toxic methods, including alage, microorganisms, plants
26
etc.. Expoiting the potential of medicinal plants, is one of the green synthesis routes and is
27
significant because the current therapeutic approaches have toxicity problems and microbial
28
multidrug resistance issues. As the metal nanoparticles have received great attention across the
29
globe, so in this study we have discussed and focused many different metallic nanoparticles
30
obtained by green synthesis using medicinal plants. We have also discussed the types, size and
31
medicinal properties like antibacterial, antifungal, anticancer, antiviral activities of
32
nanoparticales. The biomolecules, secondary metabolites and coenzymes present in the plants
33
help in easy reduction of metal ions to nanoparticles. Such nanoparticles are considered as
34
potential antioxidants and promising candidates in cancer treatment. The simplified model
35
summarises the green synthesis, its characterization using physicochemical means and their
36
biomedical applications. Succinctly, we have discussed the recent advances in green synthesis of
37
metallic nanoparticles, milestones, therapeutic applications and future perspectives of
38
biosynthesized nanoparticles from some important medicinal plants.
39
40
Keywords: Green synthesis, Nanoparticle, Nanotechnology, Medicinal plants, Antibacterial,
41
Antifungal
42
2
43
44
1. Introduction The life expectancy of human beings has increased after the immense progress in medical
45
sciences. Earlier the average life of a human being was about 50-60 years. Now it has been
46
increased to approx 70 years and above (Roser 2016). This is possible due to immense
47
contribution of applied research in medical sciences in the field of diagnostics, prevention and
48
targeted treatment (Roser 2016). The most valuable contribution of microbiological sciences
49
was the discovery of antibiotics. When first antibiotic penicillin was discovered and introduced
50
in 1940, it saved the life of many soldiers who earlier died of septic or wound infection mainly
51
caused by Staphylococcus spp (Tan and Tatsumura 2015). Soon after the introduction of
52
penicillin, Staphylococcus became resistant and use of penicillin became less relevant to treat
53
Staphylococcus infection.. During evolution, bacteria developed resistance towards
54
antimicrobial agents (Fair and Tor 2014). Also the indiscriminate use of these antibiotics have
55
added to the woes. Researchers across globe are quite aware that such irrational use of
56
antibiotics, will make the treatment difficult as antibiotics will become toothless (Ventola, 2015).
57
So the world is in the search of newer alternative of pharmaceuticals which are small and
58
capable of targeted delivery (Taylor 2016). Thus, the scientists are keen to investigate smaller
59
medicinally important molecules and nanotechnology seems to be the result of that curiosity.
60
Nanotechnology is emerging science which deals with the study of small particles or
61
nanoscale materials whose size ranges from 1-100 nm ( 1 nm = 10-9 m). Ancient system of
62
medicine in India, Ayurveda deals with the different formulations which are suggestive about
63
the nanosize range in for e.g. Swarna Bhashm, Muktashukti bhasma, Abhrak bhashma, Tamra
64
bhasma, Louha Bhasma (Pal et al., 2015;Sharma and Prajapati 2016). Bhasmas are generally a
65
metallic preparations having decoction of medicinally important herbs and it is widely used for 3
66
the treatment of various diseases (Pal et al., 2015). These bhasmas were considered to be aseptic
67
and free from toxicity in therapeutic doses which proved its enhanced efficacy (Chaudhary,
68
2011). The term nanotechnology was first given by N. Taniguchi at the international conference
69
on industrial production in Tokyo in 1974, in order to describe the very thin development of
70
materials within nanometer range. This idea was taken up by Feynman and it was later developed
71
by Drexler. In the year 2000 American President Mr. Bill Clinton showed interest in
72
nanotechnology and started funding for cutting edge research. On the similar lines, President
73
George W. Bush signed and introduced the Nanotechnology Research and Development Act.
74
This legislation made nanotechnology research a national priority and of prime importance
75
thereby forming National Technology Initiative (NNI). This nanotechnology based applied
76
research has found importance in many research institutions around the world.
77
2. Why Green synthesis ?
78
In the last few years Indian subcontinent witnessed great progress in terms of herbal based
79
products. This revolution is due to the trust of people towards Ayurvedic products or herbal based
80
products as most of the people now aware of side effects of a chemically derived or synthetic
81
antimicrobial compounds, which have adverse effects on human health. Another reason was the
82
development of antibiotic resistance to multiple drugs (Srivastava et al., 2014; Chandra et al.,
83
2017). In medical sciences the infection is controlled by the use of antibiotics, however due to
84
the emergence of Multiple Drug Resistance (MDR) bacteria, it is very much difficult to treat
85
such patients who are infected with MDR pathogenic bacteria. In the case of Urinary tract
86
infection, E. coli is the most frequently encountered bacteria and it became resistant to most of
87
the common drugs which is being used today to control the infection. This bacteria have shown
88
good response towards Gentamicin but the problem associated with this drug is its side effects. It 4
89
is nephrotoxic and could cause permanent kidney damage (Pazhayattil and Shirali 2014). So, to
90
avoid such toxic and life threatening side effects, people are shifting their dependence towards
91
herbal based antimicrobial agents which are effective, eco-friendly and relatively free from side
92
effects. Towards this we performed searching by using the keywords
93
“green AND synthesis AND nanoparticles AND plant” and results showed that India has more
94
than 1400 published papers from 1996 to 2018 and is the most active region working in this field
95
of research, followed by Iran which published about 260 papers (Fig. 1). With these keywords,
96
the search result showed that the field of materials science is promising and stands second one
97
after the Biochemistry, Genetics and Molecular Biology area containing the largest number of
98
publications (Fig. 2). For the synthesis of nanoparticle, researcher have tried different methods
99
like physical and chemical methods. However, these methods weretime consuming, expensive,
100
require sophisticated electronic or electrical equipment. These methods use toxic chemicals that
101
have many health hazards and it was not environment friendly (Chandra et al., 2019). So, green
102
synthesis including important medicinal plants were proving helpful and promising in this regard
103
(Elemike et al. 2019; Khatami et al. 2018).
104
3. Synthesis of metallic nanoparticles
105
3.1 Sol-Gel Method
106
The Sol-gel method is well known method for the synthesis of metallic NPs in which there are
107
certain essential preparation steps for the synthesis nanoparticles. Initially monomers are
108
converted to the sol (a colloidal solution) which is the precursor for subsequent gel formation
109
(Owens et al., 2016). This method has the following steps i.e. the metal undergoes hydrolysis and
110
forms metal hydroxide solution and rapid condensation leads to three-dimensional gel formation.
111
The gel is then dried and the product is rapidly converted to Xerogel or Aerogel. The 5
112
nanostructures obtained are of high purity and homogenous structure. Sol-gel process is more
113
preferred as it is economically feasible and involves low-temperature (Thiagarajan et al., 2017;
114
Owens et al., 2016).
115
3.2 Polyol Method
116
In Polyol process there is synthesis of metallic nanoparticles by using polyols which
117
acts as a reaction medium which has role of reducing agent, solvent and complexation
118
agent simultaneously with dissolved stabilizing agents (Dhand et al., 2015). It is
119
liquid phase synthesis in which polyol group such as ethylene glycol etc. reacts with
120
low cost metal salts with different proportion following the addition of sulphuric acid
121
and heating the solution upto boiling temperatures. After the reaction, solution was
122
cooled to room temperature, and the particles were separated from the liquid by
123
centrifugation and then repeatedly washed with ethanol. The resulting particles were
124
dried at room temperature till further use (Kim et al., 2006).
125
3.3 Microemulsion
126
Microemulsion solutions contain at least three components viz. polar, non polar and
127
surfactant. Microemulsions are homogeneous, isotropic and thermodynamically
128
stable solutions (Malik et al., 2012). It is one of the inorganic nanoparticle synthesis
129
method in which microemulsiom material and reactant are mixed together due to the
130
collision of water droplets of microemulsions with reactant. The precipitation occurs
131
in the nanodroplets followed by nucleation and coagulation. The resultant
132
nanoparticles surrounded by water (Rane et al., 2018). There are namely two routes
133
for synthesis of the nanoparticles viz. one micro emulsion method and two micro
134
emulsion method.
6
135
3.4 Hydrothermal synthesis
136
Nowdays the potential of rapid and continuous techniques for controlled production of
137
inorganic nanomaterials has been demonstrated (Darr and Poliakoff 1999). The
138
promising green approach are mostly water-based viz. continuous hydrothermal synthesis
139
process (Bartkowiak et al., 2018; Jaggessar and Yarlagadda, 2020). Hydrothermal
140
process is a liquid phase technology that has gained importance during years. In the
141
hydrothermal process, inside an engineered mixer having preheated water under high
142
temperature and high pressure gets reacted with aqueous metal salt solution under
143
continuous flow and nanoparticle metal oxide is the product (Darr and Poliakoff 1999).
144
The process varies and the product is dependent upon the process conditions and reagents
145
used.
146
147
4. Green synthesis routes of metal nanoparticles
148
There are different routes of green synthesis methods to synthesize nanoparticles exploiting
149
microbes and plants etc. which have been proven safe, efficient and cost-effective (Gowramma
150
et al., 2015). The different routes for the synthesis of metallic nanoparticles uses biological
151
organisms like bacteria, viruses, actinomycetes, fungi (including yeast), plant extracts etc. (Shah
152
et al., 2015). These green synthesis methods involve an eco-friendly approach using green
153
chemistry. In comparison to the above-mentioned biological entities working as an efficient
154
factories for nanoparticle synthesis, the NPs formed via plants is comparatively a straight
155
forward method which is more advantageous approach (Iravani 2011). Microbes have the ability
156
to help synthesize inorganic materials and this is a bottom-up approach. Each microbe acts in a
7
157
different manner and interacts differently with particular metallic ions. The formation of metallic
158
nanoparticles depends on cellular milieu (pH and temperature) in specific microorganisms and
159
the biochemical processing in respective microbes determines with a particular size and
160
morphology (Iravani 2014). There are different routes of green synthesis exploiting the potential
161
of the following organisms-
162
4.1 Bacteria
163
The different bacteria possesses inherent ability to reduce the heavy metals and can be
164
considered potential candidates for synthesis of nanoparticles. This reduction is a combination of
165
many factors nanoparticles and few organic functional groups present at bacterial cell wall seems
166
to be an important factor which induces reduction. In this category, the bacterial species helpful
167
in the synthesis of metallic nanoparticles are Escherichia coli, Bacillus cereus, Klebsiella
168
pneumoniae, Actinobacter sp., Lactobacillus spp., Corynebacterium sp., Pseudomonas sp. etc.
169
(Iravani 2014; Sunkar and Nachiyar 2012). Both intracellular and/or extracellular mechanisms
170
are used by bacterial cells involved in the synthesis of metallic nanoparticles. Facile biosynthesis
171
of zirconium dioxide crystalline nanoparticles were synthesized using Acinetobacter sp. KCSI1
172
(Suriyaraj et al., 2019). The gold (Au) ions were effectively reduced by using Pseudomonas
173
aeruginosa and it resulted in the extracellular synthesis of gold nanoparticles (Husseiny et al.,
174
2007). Also the reduction of palladium and its biocrystallization was observed by Desulfovibrio
175
desulfuricans (Yong et al., 2002). Regarding the yield of nanoparticles and their proper
176
synthesis, selection of correct culture media for a specific bacterial populations and the desired
177
metallic salt is very important (Roh et al., 2001; Yong et al., 2002)
178
8
179
4.2. Actinomycetes
180
There are reports about the biogenic synthesis of metal nanoparticles from actinomycetes and
181
their biomedical and therapeutic applications (Golinska et al., 2014). In the actinomycetes
182
culture, the enzymes secreted from the cell wall and cell membrane helps in the reduction of
183
silver and gold ions and the proteins help in capping and stabilization of the nanoparticle
184
formation (Sukanya et al., 2013).
185
4.3. Algae
186
Algae offers a quick and cheap route of green synthesis (Baker et al., 2013). Algae came in use
187
for NP synthesis because the nucleation and growth of crystal was accelerated due to the
188
presence of negative charge on the surface of algal cells and also the industrial synthesis is at
189
very low cost. The metabolites secreted by the culture medium of the Chaetomorpha linum algae
190
causes the reduction of silver nitrate. Flavonoids and terpenoids in the extract acted as effective
191
capping and stabilizing agents and also they helped in the formation of NPs which were useful in
192
medical fields (Kannan et al., 2013). Spirulina platensis mediated biosynthesis of gold
193
nanoparticles and the bio functionality was tested by its antibacterial activity against S. aureus
194
and B. subtilis (Suganya et al., 2015). Polysaccharides of algal species helps in controlling the
195
size and shape of silver nanoparticles. Few marine algae are efficient in nanoparticle synthesis
196
and the NPs are useful also (El-Rafie et al., 2013).
197
4.4. Fungi
198
Another group of organisms like fungi have enzymes and proteins which can reduce metal ions
199
into nanoparticles and also stabilize the resulting nanoparticles (Khandel and Shahi 2018).
200
Plethora of different proteins in fungi convert the metallic salts into corresponding nanoparticles 9
201
and the process is very fast. There are many fungi viz. Aspergillus sp., Fusarium sp., and
202
Penicillium sp. which have their biosynthetic ability to create both silver and gold nanoparticles
203
(Vigneshwaran et al., 2007; Philip 2009; Kathiresan 2009). Trichothecium sp, an alkali tolerant
204
fungus were used in biosynthesis of gold nanoparticles (Ahmad et al., 2005). Green synthesis of,
205
silver nanoparticle from soil fungus Penicillium italicum was carried out and tested effectively
206
against multi drug resistance (MDR) pathogens (Nayak et al., 2018). In comparison of bacteria,
207
fungi contains and efficiently secrete different proteins and several enzymes per unit biomass for
208
proper synthesis of metallic nanoparticles due to which yield of nanoparticles is increased
209
(Narayanan and Sakthivel 2010). Yeasts are simple eukaryotes and have proper post-translational
210
methods which helps proteins and enzymes for efficient function. Silver nanoparticles were used
211
in the biotransformation using Saccharomyces cerevisiae (Korbekandi et al., 2016). The
212
synthesis of nanoparticles were in the cells, inside cell membrane and attached to cell membrane
213
and also outside of the yeast cells (Korbekandi et al., 2016). A silver tolerant yeast strain MKY3
214
was used in green synthesis of silver nanoparticles extracellularly (Kowshik et al., 2003). Thus
215
they are preferred in comparison to bacteria due to mass production of nanoparticles and easy
216
handling and control in laboratory using simple nutrients (Moghaddam et al., 2015).
217
4.5. Plants
218
The routes via plants especially medicinal plants offers extra advantages and also it does not
219
require any complex protocols or methodologies. In the case of microbes, there are multi-step
220
process including isolation of potential microbe, specific culture preparation and sub-
221
culturing, maintenance of culture etc. Furthermore, the process via plants is comparatively
222
easy for scaling up, for large scale production of nanoparticles (Jha et al., 2009; Bar et al.,
223
2009). In green synthesis method involving the plant materials such as leaves, root, stem, 10
224
bark, flower, fruit etc. (Akhtar et al., 2013) which act as reducing and stabilizing agent are
225
mixed with desired metal solution such as Silver nitrate (AgNO3), Titanium oxide (TiO2),
226
Zinc Oxide (ZnO), Zinc acetate (Zn(CH3COO).2H2O), Hydrogen tetrachloroaurate
227
(HAuCl4), hexachloroplantic acid (H2PtCl6.6(H2O), Copper (II) sulfate pentahydrate salt
228
(CuSO4.5H2O) and other metals (Figure 3). Gopinath et al. (2012) synthesized silver
229
nanoparticles from the medicinal plant, Tribulus terrestris L. fruit bodies and reported the
230
spherical shaped NPs having size between 16-28 nm. These green synthesized AgNPs were
231
tested against Staphylococcus aureus, Escherichia coli, Streptococcus pyogens,
232
Pseudomonas aeruginosa, Bacillus subtilis and and found to have bactericidal activity
233
against all tested isolates of multi-drug resistant bacteria. Also the silver nanoparticles from
234
leaf of Tribulus terrestris bearing medicinal properties displayed antibacterial activity
235
(Gopinath et al. 2015). The phytomediated synthesis of silver and gold nanoparticle from
236
Mentha piperita leaves and their antimicrobial activity was evaluated against human
237
pathogens E. coli and Staphylococcus aureus. The gold nanoparticle was found superior than
238
silver nanoparticles (Mubarakali et al., 2011). The silver nanoparticle synthesized from the
239
leaves of Podophyllum hexandrum inhibited the cellular mechanism of HeLa by DNA
240
damage and caspase-mediated cell death. (Jeyaraj et al., 2013). Titanium dioxide
241
nanoparticles ( TiO2NPs) were synthesized from Cissus quadrangularis extract was reported
242
to have significant bactericidal activity against E. coli and Staphylococcus (Priyadarshani et
243
al., 2019). Cinnamon was used as cinnamon as reductant and stabilizer in green synthesis of
244
silver NPs and antibacterial activity was observed (Premkumar et al., 2018). The
245
biosynthesized zinc oxide nanoparticles from leaf of Justicia wynaadensis which is a
246
medicinal herb showed antimitotic and DNA-binding potential (Hemanth Kumar et al.,
11
247
2019). The extract of common herbal plant, Caesalpinia pulcherrima was used for silver
248
nanoparticle synthesis and proved cytotoxic on HCT116 cell lines (Deepika et al., 2020). The
249
phytomediated synthesis of Zinc oxide nanoparticle was described by Chandra et al., (2019)
250
in which Berberis aristata leaves was used for the synthesis of ZnONPs. Francis et al.(2017)
251
synthesisized and characterized gold and silver nanoparticle from the leaf extract of
252
Mussaenda glabrata by using green synthesis method. A medicinal plant, Cissus
253
quadrangularis was used for facile biosynthesis of copper oxide nanoparticles which were
254
used as potential antifungal agents against Aspergillus niger, and Aspergillus
255
flavus (Devipriya & Roopan 2017). The green biosynthesis of zinc oxide nanoparticles by
256
the use of extract from the flower of Nyctanthes arbor-tristis and their antifungal potential
257
against many phytopathogens (Jamdagni et al., 2018). A medicinal herb Rosmarinus
258
officinalis L. (rosemary) was used for green synthesis of iron nanoparticles. Rosemary-
259
FeNPs proved to have cytotoxicity on 4T1 and C26 cancer cell lines (Farshchi et al., 2018).
260
The facile biosynthesis of nanoparticles by using plants especially medicinal plants is safe,
261
less time needed and economically viable in comparison to other biological organisms like
262
microbes etc. (Shah et al., 2015; Mittal et al., 2013). The green synthesized nanoparticles
263
possess increased antimicrobial activity in comparison to the other nanoparticles. This
264
activated antimicrobial activity may be the result synergistic action of few proteins which
265
function in capping and subsequently stabilizing the biosynthesized nanoparticles (Roy et al.,
266
2019).
267
5. Characterization of nanoparticle
268
For nanoparticle synthesis, reaction mixture is exposed to sunlight directly and the color change
269
is observed to determine nanoparticle formation.The agglomeration of NPs is avoided after 12
270
removing from sunlight once the color intensities are stored in dark. This nanopowder is further
271
subjected to characterization using physicochemical means. After synthesis of metal nanoparticle
272
it is essential to characterize the synthesized NPs (Figure 3) to know whether the synthesized
273
metal nanoparticle are in the nano range and also for shape and chemical nature. Various
274
techniques are used for the study of synthesized nanoparticle. X ray diffraction (XRD) analysis
275
of the green synthesized nanopowders is carried out and the average crystallite size of
276
nanocrystals was calculated using Scherrer's equation (Scherrer 1918). The maximum
277
absorbance of the synthesized nanoparticle was measured by UV-Vis Spectrometry and Fourier
278
transform- infra red (FTIR) spectroscopy helps in identifying the functional groups involved.
279
The shape of the nanopowders were analysed using Scanning electron microscopy and the
280
elemental compositions of the nanoparticle was analysed using Energy dispersive X-ray
281
spectroscopy (EDX). A noninvasive method is dynamic light scattering (DLS) which is used to
282
measure the size distribution of the synthesized nanoparticles. DLS method depends on the
283
nanoparticle interaction with light and relies on Rayleigh scattering. These above mentioned
284
techniques were used for the characterization of the following biosynthesized nanoparticles from
285
medicinal plants e.g. silver nanoparticles from cinnamon (Premkumar et al., 2018), Caesalpinia
286
pulcherrima (Deepika et al., 2020), zinc oxide nanoparticles from Justicia wynaadensis
287
(Hemanth Kumar et al., 2019), Berberis aristata (Chandra et al., 2019), Nyctanthes arbor-
288
tristis (Jamdagni et al., 2018), Solanum nigrum (Ramesh et al., 2015), gold and silver
289
nanoparticle from Mussaenda glabrata (Francis et al., 2017), Mentha piperita (Mubarakali et al.,
290
2011), copper oxide nanoparticles from Cissus quadrangularis (Devipriya & Roopan 2017) and
291
iron nanoparticles from Rosmarinus officinalis (Farshchi et al., 2018). The confirmation of the
13
292
biosynthesized crystals were done by the physico-chemical techniques mentioned above and
293
later the biofunctionality was ascertained.
294
6. Mechanism of action of nanoparticles
295
The modern medicine system is more popular among all form of medicines due its
296
immediate action and life saving effects. However, traditional system of medicines takes
297
longer time but it acts on the root cause of the diseases.. The Homeopathic medicines are
298
based on the nanoparticles and they consist of highly reactive nanoparticles (Bell and
299
Koithan, 2012). The nanoparticles display their cytotoxicity by inducing apoptosis or by
300
inducing cell cycle arrest (de Stefano et al. 2012). The smaller size of selenium NPs
301
enters the cancerous cells via nucleus and does DNA breakage which ultimately leads to
302
cell death. The selenium NPs does cytotoxic effects by the disruption of glutathione and
303
thioredoxin systems by generation of reactive oxygen species (Menon et al., 2018).
304
Mechanism of action of antibacterial activity by the biosynthesized nanoparticles are due
305
to the following (i) Reactive Oxygen Species (ROS) generation (ii) bacterial protein
306
denaturation (iii) entry in the bacterial cell wall and causes cell death. (iv) disrupting
307
bacterial respiratory chain that leads to cell death (v) formation of asymmetrically shaped
308
pits in the cell membrane and changes permeability of membrane, thereby causing release
309
of lipopolysaccharides and membrane proteins (Rajeshkumar and Bharath, 2017). These
310
may be the putative methods by which the nanoparticles exhibit their action and
311
biofunctionality. Zinc nanoparticles disrupts plasma membrane of bacteria but the cause
312
of interference in permeability of cell is not well established. Some hypothesis may be
313
ascribed for this phenomenon viz. the nanoparticles exhibit their antibacterial activity via
14
314
induction of oxidative stress and release of metal ion etc. (Chandra et al. 2019) and also
315
formation of hydrogen peroxide from the surface of zinc oxide NPs (Rai et al. 2009).
316
7. Medicinal value of Plants
317
The burgeoning incidence of diseases caused by MDR pathogenic bacteria in developed and
318
developing countries put immense pressure on medical fraternity to search the alternate treatment
319
of these resistant microorganisms. In India, people are now showing faith to alternate systems of
320
medicines such as Ayurveda, Homoeopathic and Unani practices. All these systems are directly
321
or indirectly use medicine which is already described in ancient literature. As mentioned in the
322
previous section that different kinds of Bhasmas as prescribed for the treatment of various
323
ailments fall within the permissible limit of nanosize (Sharma and Prajapati 2016). The
324
researchers from different countries reported the synthesis of different metal nanoparticles from
325
medicinal plants and have shown important therapeutic properties such as antioxidant activity,
326
antimicrobial activity, wound healing properties, insecticidal activity, anticancer activity,
327
immunomodulatory activity, antidiabetic activity, hepatoprotective activity etc. (Table 1). Thus,
328
a new era of nanomedicine (Muhammad et al. 2019) is on the rise and use of medicinal plants
329
will immensely benefit through their use in formation of metallic nanoparticles..
330
7.1. Applications of medicinal plants as nanomedicine
331
The application in pharmaceutical and biotechnology industries by the use of nanomedicine has
332
seen profound effects (Wagner et al., 2006; Shi et al., 2011). Approximately 100 products of
333
nanomedicines clinically approved are finding prominence in the field ranging from drug
334
delivery, bio-imaging, biomaterials and diagnostic or other medical devices (Etheridge et al.,
335
2013). The drugs which we ingest remains available in a very low amount in the blood streams
15
336
and is termed as bioavailabilty. So, to achieve that bioavailability level, dose optimization is
337
necessary and the drug which we take should have a specific target. So, to get appropriate
338
bioavailability, theoretically heavy quantity of drugs must be taken but that will result in more
339
side effects. The nanotechnology approach is promising technology and has proved that it has
340
site specific drug delivery (Hanafy et al. 2019; Wang et al. 2017). Due to this approach the
341
required dose of drug will be used and side-effects can be reduced substantially. The use of drugs
342
in small quantities and the specific target can reduce the cost of drugs and even reduce pain to
343
the patients (Nikalje, 2015). The synthesized polyethylene glycol (PEG) nanoparticles carrying
344
antibiotics and termed as “PEGylation” helps in improving drug efficiency and helps delivery of
345
genes to target cells. The coatings by PEG helps administration of nanoparticle formulations in
346
efficient manner. These formulations were evaluated for the control of bacterial infection, and it
347
was found to efficiently target bacterial infection more precisely inside the body (Suk et al.,
348
2016). The nano delivery of particles, containing a sub-layer of pH sensitive chains of the amino
349
acid histidine, is used to destroy bacteria that have developed resistance to antibiotics because of
350
the large dose and sustained release of the drug. Applications of nanotechnology is nowdays
351
used efficiently to treat various infectious diseases (Radovic-Moreno et al. 2012). The resin
352
based composites having an inorganic residues as filler particles of different sizes in the range of
353
supra micron, submicron and nano level are used in dentistry (Schmalz and Arenholt 2009). In
354
dental implants and surgery, the resin content of the composites is reduced by filling it with
355
nanoparticles. Nanohybrids are the composites and they are a mix of small and large particles in
356
a resin based composites but the nano-composites are the ones having only nano particles
357
(Albers 2002). The filler particles in a resin based composites vary differently in composition of
358
nanoparticles. Earlier the resin-based nanocomposites used to contain the quartz particles (Albers
16
359
2002). The filler nanoparticles gave new dimension to the research in dentistry. With the advent
360
of nanotechnology, silver nanoparticles have proved to be efficient antimicrobial agents due to
361
its interactions with bacteria (Rai et al., 2009; Lok et al., 2006). Silver nanoparticles (AgNPs)
362
were used in filling dental caries from the last few years (Correa et al., 2015; Priyadarsini et al.,
363
2018) for preventing bacterial infections and colonization (Manikandan et al., 2017). These
364
nanoparticles have been used in many dentistry areas like endodontics (Samiei et al. 2013; Lotfi
365
et al. 2011), implantology (Zhao et al., 2011), restorative dentistry (Cheng et al., 2011) and
366
dental prosthetics (Nam 2011). In dental implants also the silver nanoparticles have been
367
successfully used (Flores et al. 2010; Zhao et al., 2011). Durner et al. (2011) and Cheng et al.
368
(2012) have reported the use of silver NPs in restorative dentistry. The nanocomposites
369
containing acrylic resins and silver nanoparticles possess antimicrobial effect against bacteria
370
and also provided better strength in dental treatment (Kassaee et al., 2008).The data on the
371
release of silver nanoparticlesfrom dental implants or fillings are rare.
372
The oral bacteria Streptococcus mutans was inhibited by the antibacterial action of the
373
silver particles which were released from the resin-based composites having silver ion-implants
374
as fillers (Yamamoto et al. 1996). Therefore, from all these studies it can be assumed that either
375
silver nanoparticles as such are released or the silver ions from these particles have beneficial
376
effects. The silver nanoparticle incorporation were aimed for avoiding the microbial colonization
377
thereby, increasing overall oral health.
378
7.2. Nanoparticles in Urinary Tract Infection
379
UTI are most common infection in human beings mainly caused by bacteria and Candida spp. It
380
is most commonly encountered in females and affecting people of all ages. The worldwide
17
381
incidence rate of UTI was 150 million people per year (Swify et al., 2015; Flores-Mireles et al.,
382
2015). E. coli is responsible for approx. 80% of urinary tract infections (UTIs) and while
383
choosing appropriate antibiotics such bacteria should be targeted (Kang et al., 2018).
384
The UTI affects urinary tract including urethra, ureter and kidney. The most frequent
385
microorganism encountered in urine examination is E. coli, followed by Klebsiella, enterococci,
386
groupB streptococci, Pseudomonas, and Proteus mirabilis (Srinivas et al., 2014). UTI is
387
experienced by about 12% of men and 40% women at least once during their lifetime but 40%
388
women display recurrent UTI (Foxman, 2010; Ikäheimo et al., 1996). UTIs are prevalent during
389
the medical complications of pregnancy and this increased incidence during pregnancy is due to
390
the physiological changes that occurs in the genitourinary tract of females during pregnancy
391
(Abdullah and Al-Moslih, 2005; Jeyabalan A, Lain, 2007).
392
Most of the antibiotics used for the control of UTI infections are now ineffective due to
393
development of resistance against these antibiotics (Lee et al., 2018). These urinary tract
394
pathogens acquire resistance due to acquistation of resistance gene acquired through horizontal
395
gene transfer or by other means such as irrational administration of antibiotic without knowing
396
the sensitive pattern of causal microorganisms (Lee et al., 2018). Chandra et al. (2019),
397
synthesized zinc oxide nanoparticle from Berberis aristata and evaluated its antibacterial activity
398
against urinary tract pathogens isolated from urine sample of patients and found that it has
399
significant antibacterial activity against E. coli, Staphylococcus aureus, Klebsiella pneumonia
400
but it has not shown positive response against Proteus spp and S. typhi. The green synthesized
401
copper oxide nanoparticles from indian medicinal plant, Tabernaemontana divaricate leaf, has
402
effective antibacterial activity against the urinary tract pathogens (Sivaraj et al. 2014).
18
403
Ravikumar et al. (2012) also observed in vitro antibacterial activity of Al2O3 nanoparticle as
404
antibacterial agents against urinary bacterial pathogens.
405
7.3. Antiparasitic activity of nanoparticles
406
Malaria is one of the most prevalent parasitic diseases and spread through the female Anopheles
407
mosquito. As per the data given by National Vector Borne Disease control program number of
408
death has been reduced tremendously (NVBDCP, 2012). In India incidence of chloroquine
409
resistance was reported from various places of India and that resistance was due to the K767
410
mutations in pfcrt gene of P. falciparum (Vinayak et al., 2003). So, there is need of some
411
alternate and effective strategy to control malaria in resistant cases. There are several reports
412
which describes the effectiveness of silver nanoparticle (AgNPs). The AgNPs synthesized from
413
the leaf of Andrographis paniculata was investigated for antiplasmodial activity against P.
414
falciparum at 100 µg/mL concentration and it showed 83% inhibition (Paneerselvam et al.,
415
2011). AgNPs synthesized from the leaf extract of Euphorbia hirta also showed the total
416
reduction of P. falciparum (Paneerselvam et al., 2015). Generally, researchers have found
417
different botanicals to control mosquitoes by acting as larvicidal and pupicidal (Prabhu et al.,
418
2011). The green synthesis nanoparticle from plants are reported to have oviposition deterrent,
419
mosquitocidal and inhibitory effect on adult stage of mosquitoes (Soni et al., 2014; Benelli,
420
2016). Silver nanoparticles biosynthesized from Feronia elephantum plant had larvicidal activity
421
against third instar larvae of Anopheles stephensi, Culex quinquefasciatus and Aedes Aegypti
422
(Veerakumar et al., 2014). Green synthesized gold nanoparticles from the Cymbopogon citratus
423
plant of medicinal importance, was observed to be effective against various mosquitos vector
424
(Murugan et al., 2015). The fungal-mediated green synthesis of silver and gold nanoparticles
425
(AgNPs and AuNPs) were effective as larvicidal agents and their efficiency was shown against 19
426
the Anopheles stephensi, Culex quinquefasciatus and Aedes Aegypti (Soni et al., 2012). Dengue
427
fever reduces platelet counts and is fatal to the patient. However, no efficient treatment apart
428
from the platelet transfusion is possible. However, herbs are known to have potential to increase
429
the platelet counts and that can be exployed by green synthesis. Recently, gold nanoparticles
430
from Artemisia vulgaris (Sundararajan et al., 2017) and Cymbopogon citratus (Murugan et al.,
431
2015) were shown to have inhibitory action against dengue fever vector Aedes aegypti.
432
7.4. Antiviral activity of nanoparticles
433
In recent years, there is a burgeoning incidence of a viral infection such as viral hepatitis, HIV,
434
Swine flu and SARS virus, , West Nile virus, monkey pox virus, Hantavirus, Nipah virus,
435
Hendravirus, chikungunya virus are causal agents for other viral borne infection (von Overbeck
436
2003; Daszak et al., 2013). The treatment available in allopathic practice is an administration of
437
the antiviral drug e.g. acyclovir which inhibits viral multiplication but the treatment suffers from
438
many side effects and fail to complelely remove the virus particles from the patient’s body. The
439
life cycle and multiplication of virus follows steps i.e. virus adsorption, virus penetration,
440
uncoating, expression of the virus genome, replication of the genome, protein synthesis,
441
assembly and release of the virus. The drugs developed for viral infection have action on one of
442
the above mentioned steps. The metal nanoparticle e.g. silver nanoparticles has shown promising
443
response against viral infection by inhibiting any of the steps listed above (Galdiero et al., 2011).
444
The silver nanoparticle has antiviral activity against HIV infected cells (Sun et al., 2005; Lara et
445
al., 2010), Hepatitis B Virus (Lu et al., 2008), Herpes simplex virus type I (Baram-Pinto et al.,
446
2009), monkey pox virus (Rogers et al., 2008) and chikungunya virus (Sharma et al., 2019).
447 448
7.5. Antiproliferative/anticancer activity/cytotoxic effect of metallic nanoparticles 20
449
Cancer stands out to be one of the greatest scourge to human life. The standards in treatment and
450
diagnosis of the disease have been elevated by the nanotechnology and considered as the most
451
encouraging introduction for cancer therapy. In the modern system of medicine, some effective
452
treatments available to control or remove the cancerous cells from the body includes
453
chemotherapy, radiation and surgical removal of cancerous tissues. The phytosynthesized
454
nanoparticle has shown some hope for certain type of cancers. Silver nanoparticles from leaf
455
extract of Melia azedarach were active against the HeLa cervical cancer cell lines (Sukirtha et
456
al., 2011). The silver nanoparticle synthesized from Nepeta deflersiana plant have shown
457
anticancer properties against cervical cancer (i.e. HeLa cells) (Al-Sheddi et al., 2018). The MTT
458
assay of silver nanoparticle synthesized from the aqueous leaf extract of pomegranate (Punica
459
granatum) shown anticancer properties against cervical cancer (Sarkar and Kotteeswaran, 2018).
460
Copper oxide nanoparticles were formed from Phaseolus vulgaris (Black bean) and can induce
461
apoptosis and acts as inhibitory action of HeLa cells (Nagajyothi et al., 2017) Mousavi et al.
462
(2018) reported that phytosynthesized silver nanoparticles from Artemisia turcomanica leaf
463
have to cytotoxic activity against gastric cancer cells (AGS) as well as normal fibroblast cells
464
(L–929) by MTT assay. The silver nanoparticles from Piper longum showed cytotoxic effects on
465
HEp-2 cancer cells (Jacob et al., 2011). Gold nanoparticles Allium cepa were useful against the
466
MCF-7 breast cancer cells (Parida et al., 2011). The silver nanoparticles synthesized from the
467
plant have now proven to have potential to control cancer (Abdel-Fattah and Ali, 2018).
468
8. Conclusions
469
The green synthesis of nanoparticles poses research interest to scientists across the globe, due to
470
its applications. Medicinal plants contain phytometabolites of therapeutic values and are
471
currently exploited for benefit to mankind. This method is found to be promising and eco21
472
friendly for the synthesis of metal nanoparticles. Our review article discussed the biosynthesized
473
metallic nanoparticles from various medicinal plants including their pharmaceutical and
474
therapeutic applications in different sectors like biomedical, drug delivery, nanomedicine and,
475
diagnostics. Since the nanoparticles from medicinal plants are free from toxic contaminants, they
476
are well suited in medical sciences and therapeutics. The biosynthesized nanoparticles from
477
medicinal plants have gained the level of competency or biofunctionality as compared to their
478
physically and chemically synthesized nanoparticles. The potential of nanotechnology is
479
emerging in newer fields like DNA nanotechnology which may help to reduce drug toxicity and
480
enhance the efficiency of drug targeting.
481
Acknowledgements- The authors are thankful to Dr. Hemant Ritturaj Kushwaha, Jawaharlal
482
Nehru University, New Delhi, India for critically reading the manuscript.
483
Funding- This research did not receive any specific grant from funding agencies in the public,
484
commercial, or not-for-profit sectors.
485
Legends
486
Figure 1- (Upper) Number of papers reporting the keyword search
487
“green AND synthesis AND nanoparticles AND plant” from SCOPUS (data were analyzed
488
form 1996 to 2018) (Lower) Geographical map depicting India, with more than 1400 published
489
papers rom 1996 to 2018 followed by Iran that published about 260 papers, as the most active
490
region working in this field of research.
491
Figure 2- The field of materials science is second one after the Biochemistry, Genetics and
492
Molecular Biology area containing the largest amount of publications.
22
493
Figure 3- Green synthesis of metallic nanoparticles, their physico-chemical characterization and
494
biomedical applications.
495
Table 1- Metallic nanoparticles synthesized from different medicinal plants, plant part used, size
496
in nm, and their medicinal properties.
497
References
498
Abdel-Fattah, W.I., Ali, G.W., 2018. On the anti-cancer activities of silver nanoparticles. J.
499
Appl. Biotechnol. Bioeng. 5(1), 43-46. DOI: 10.15406/jabb.2018.05.00116.
500
Abdullah, A.A., Al-Moslih, M. I., 2005. Prevalence of asymptomatic bacteriuria in pregnant
501 502
women in Sharjah, United Arab Emirates. East. Mediterr. Health. J. 11, 1045-1052. Ahmad, A., Senapati, S., Khan, M.I., Kumar, R., Sastry, M., 2005. Extra-/intracellular,
503
biosynthesis of gold nanoparticles by an alkalotolerant fungus, Trichothecium sp. J.
504
Biomed. Nanotechnol. 1, 47-53.
505
Ahmad, N., Sharma, S., 2012. Green synthesis of silver nanoparticles using extracts of Ananas
506
comosus. Green. Sustainable. Chem. 2 (4) Article ID: 24781
507
DOI:10.4236/gsc.2012.24020.
508 509 510 511 512
Akhtar, M.S., Panwar, J., Yun, Y.S., 2013. Biogenic synthesis of metallic nanoparticles by plant extracts. ACS. Sustain. Chem. Eng. 1 (6), 591-602. Albers, H. F., 2002. Resin in tooth coloured restoratives. Principle and technique 9th Edition; 82273. Al-Sheddi, E. S., Farshori, N. N., Al-Oqail, M. M., Al-Massarani, S. M., Saquib, Q., Wahab
513
R., Musarrat , J., Al-Khedhairy, A.A., Siddiqui, M. A., 2018. Anticancer Potential of
514
Green Synthesized silver nanoparticles using extract of Nepeta deflersiana against
515
Human Cervical Cancer Cells (HeLA). Bioinorganic. Chem. Appl. Article ID 9390784,
516
https://doi.org/10.1155/2018/9390784.
23
517
Ankanna, S., Prasad, T.N.V.K.V., Elumalai, E.K., Savithramma, N., 2010. Production of
518
Biogenic silver nano particles using Boswellia ovalifoliolata stem bark. Dig. J. Nano.
519
Mat.Biostruct. 5, 369-372.
520
Arunachalam, K.D., Annamalai, S. K., Hari, S. 2013 One-step green synthesis and
521
characterization of leaf extract-mediated biocompatible silver and gold nanoparticles
522
from Memecylo numbellatum. Int. J. Nanomedicine. 8, 1307-1315.
523
Bala, N., Srimoyee, S., Chakraborty, M., Moumita, M., Das, S., Basu, R., Nandy, P., 2015
524
Green synthesis of zinc oxide nanoparticles using Hibiscus subdariffa leaf extract: Effect
525
of temperature on synthesis, anti-bacterial activity and anti-diabetic activity. RSC. Adv.
526
5, 4993-5003.
527
Banerjee, J., Narendhirakannan, R.T., 2011. Biosynthesis of silver nanoparticles from Syzygium
528
cumini (L.) seed extract and evaluation of their In Vitro antioxidant activities. Dig J.
529
Nano. Biostruct. 6(3), 961-968.
530
Bar, H., Bhui, D.K., Sahoo, G.P., Sarkar, P., de Sankar, P., Misra, A., 2009. Green synthesis of
531
silver nanoparticles using latex of Jatropha curcas. Colloids. Surf. A. 339, 134-139.
532
Baram-Pinto, D., Shukla, S., Perkas, N., Gedanken, A., Sarid, R., 2009. Inhibition of herpes
533
simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane
534
sulfonate. Bioconjug. Chem. 20, 1497-1502.
535
Bartkowiak, A., Suchanek, K., Menaszek, E., Szaraniec, B., Lekki, J., Perzanowski, M.,
536
Marszalek, M., 2018. Biological effect of hydrothermally synthesized silica nanoparticles
537
within crystalline hydroxyapatite coatings for titanium implants. Mat. Sci. Eng. C 92, 88-
538
95.
539
Bell, I. R., Koithan, M., 2012. A model for homeopathic remedy effects: low dose nanoparticles,
540
allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive
541
system. BMC. Complement. Alt. Med. 12, 191 doi: 10.1186/1472-6882-12-191.
542 543
Benelli, G., 2016. Plant-mediated biosynthesis of nanoparticles as an emerging tool against mosquitoes of medical and veterinary importance: A Review. Parasitol. Res. 115, 23-34. 24
544
Chandra, H., Patel, D., Kumari, P., Jangwan, J.S., Yadav, S., 2019. Phytomediated synthesis of
545
zinc oxide nanoparticle of Berberis aristata: Characterisation, antioxidant activity and
546
antibacterial activity with special reference to urinary tract infection. Mat. Sci. Engg. C.
547
102, 212-220.
548
Chandra, H., Bishnoi, P., Yadav, A., Patni, B., Mishra, A. P., Nautiyal, A.R., 2017.
549
Antimicrobial resistance and the alternative resources with special emphasis on plant-
550
based antimicrobials-A Review. Plants. 6, 16.
551
Chandran, S.P., Chaudhary, M., Pasricha, R., Ahmad, A., Sastry, M., 2006. Synthesis of gold
552
nanotriangles and silver nanoparticles using Aloe vera plant extract. Biotechnol.
553
Progress. 22, 577-583.
554 555
Chaudhary, A., 2011. Ayurvedic Bhasma: Nanomedicine of ancient India-Its global contemporary perspective. J. Biomed. Nanotech. 7(1) 68-69.
556
Cheng, L., Weir, M. D., Xu, H. H., Antonucci, J.M., Kraigsley, A. M., Lin, N. J., , Lin-Gibson,
557
S., Zhou, X., 2012. Antibacterial amorphous calcium phosphate nanocomposites with a
558
quaternary ammonium dimethacrylate and silver nanoparticles. Dental. Mat. 28(5) 561-
559
572.
560
Cheng, L., Weir, M.D., Xu, H.H.K. et al., 2012. Effect of amorphous calcium phosphate and
561
silver nanocomposites on dental plaque microcosm biofilms. J. Biomed. Mat. Res. B.
562
Applied Biomaterials. 100(5), 1378-1386.
563 564 565 566
Correa, J.M., Mori, M., Sanches, H.L., da Cruz, A.D., Poiate, E., Jr., Poiate, I.A., 2015. Silver nanoparticles in dental biomaterials. Int. J. Biomater. 485275. Darr, J. A., Poliakoff, M., 1999. New directions in inorganic and metal organic coordination chemistry in Supercritical Fluids. Chem. Rev. 99, 495-541.
567
Daszak, P., Zambrana-Torrelio, C., Bogich, T.L., Fernandez, M., Epstein, J.H., Murray, K.A.,
568
Hamilton, H., 2013. Interdisciplinary approaches to understanding disease emergence:
569
the past, present, and future drivers of Nipah virus emergence. Proc. Natl Acad. Sci.
570
USA. 110, 3681-3688. 25
571 572 573
De Stefano D., Carnuccio R., Maiuri M.C., 2012. Nanomaterials Toxicity and Cell Death Modalities. J. Drug Deliv. doi: 10.1155/2012/167896. Deepika, S., Selvaraj, C.I., Roopan, S.M., 2020 Screening bioactivities of Caesalpinia
574
pulcherrima L. swartz and cytotoxicity of extract synthesized silver nanoparticles on
575
HCT116 cell line. Mat. Sci. Eng. C 106, Article 110279.
576
https://doi.org/10.1016/j.msec.2019.110279.
577
Devipriya, D., Roopan, S.M., 2017. Cissus quadrangularis mediated ecofriendly synthesis of
578
copper oxide nanoparticles and its antifungal studies against Aspergillus niger,
579
Aspergillus flavus. Mater. Sci. Eng. C. 80, 38-44.
580
Dhand, C., Dwivedi, N., Loh, X.J., Ying, A.N.J., Verma, N.K., Beuerman, R.W.,
581
Lakshminarayanan, R., Ramakrishna, S., 2015. Methods and strategies for the synthesis
582
of diverse nanoparticles and their applications: A comprehensive overview. RSC.
583
Adv. 5, 105003-105037.
584
Dipankar, C., Murugan, S., 2012. The green synthesis, characterization and evaluation of the
585
biological activities of silver nanoparticles synthesized from Iresine herbstii leaf aqueous
586
extracts. Colloids. Surf. B. 98, 112-119.
587
Divyapriya. S.1., Sowmia. C., Sasikala. S., 2014. Synthesis of zinc oxide nanoparticle and
588
antimicrobial activity of Murraya koeiniggi. World. J. Pharmacy. Pharm. Sci. 3(12),
589
1635-1645.
590 591 592
Dobrucka, R., Długaszewska, J., 2016. Biosynthesis and antibacterial activity of ZnO nanoparticles using Trifolium pratense flower extract. Saudi. J. Biol. Sci. 23(4), 517-523. Durner, J., Stojanovic, M., Urcan, E., Hickel, R., Reichl, F.X., 2011. Influence of silver nano-
593
particles on monomer elution from light-cured composites. Dental. Mat. 27(7), 631-636.
594
Elemike, E.E., Uzoh, I.M., Onwudiwe, D.C., Babalola, O.O., 2019. The Role of Nanotechnology
595
in the Fortification of Plant Nutrients and Improvement of Crop Production. Appl. Sci.
596
9(3), 499.
26
597
Elumalai, K., Velmurugan, S., 2015. Green synthesis, characterization and antimicrobial
598
activities of zinc oxide nanoparticles from the leaf extract of Azadirachta indica (L.).
599
Appl. Surface Sci.345, 329-336.
600
Etheridge, M.L., Campbell, S.A., Erdman, A.G., Haynes, C.L., Wolf, S.M., McCullough, J.,
601
2013. The big picture on nanomedicine: the state of investigational and approved
602
nanomedicine products. Nanomedicine. 9:1-14.
603
Farshchi, H.K., Azizi, M., Jaafari, M.R., Nemati, S.H., Fotovat, A., 2018 Green synthesis of iron
604
nanoparticles by rosemary extract and cytotoxicity effect evaluation on cancer cell lines.
605
Biocatal. Agric. Biotechnol. 16:54-62.
606
Flores, C. Y., Diaz, C., Rubert, A., Benítez, G. A., Moreno, M.S., Fernández Lorenzo de Mele,
607
M. A., Salvarezza, R.C., Schilardi, P.L., Vericat, C., 2010. Spontaneous adsorption of
608
silver nanoparticles on Ti/TiO2 surfaces. Antibacterial effect on Pseudomonas
609
aeruginosa. J. Colloid. Interface. Sci. 350(2), 402-408.
610
Foxman, B., 2010. The epidemiology of urinary tract infection. Nat. Rev. Urol. 27, 653-660.
611
Francis, S., Joseph, S., Koshy, E. P., Mathew, B., 2017. Green synthesis and characterization of
612
gold and silver nanoparticles using Mussaendo glabrata leaf extract and their
613
environmental applications to dye degradation. Environment Science Pollution Research
614
International 24, 17347-17357.
615
Galdiero, S., Falanga, A., Vitiello, M., Cantisani, M., Marra, V., Galdiero, M., 2011. Silver
616
nanoparticles as potential antiviral agents. Molecules 16 (10), 8894-8918.
617
10.3390/molecules16108894.
618
Gavhane, A.J, Padmanabhan, P., Kamble, S.P., Jangle, S.N., 2012. Synthesis of silver
619
nanoparticles using extract of Neem leaf and Triphala and evaluation of their
620
antimicrobial activities. Int. J. Pharm. Bio. Sci. 3, 88-100.
621
Golinska, P., Wypij, M., Ingle, A.P., Gupta, I., Dahm, H., Rai, M., 2014. Biogenic synthesis of
622
metal nanoparticles from actinomycetes: Biomedical applications and cytotoxicity. Appl.
623
Microbiol. Biotechnol. 98, 8083-8097. 27
624
Gopinath, V., MubarakAli, D., Priyadarshini, S., Priyadharsshini, N.M., Thajuddin, N.,
625
Velusamya, P., 2012. Biosynthesis of silver nanoparticles from Tribulus terrestris and its
626
antimicrobial activity: A novel biological approach. Colloids. Surfaces. B. Biointerfaces.
627
96, 69- 74.
628
Gopinath, V., Priyadarshini, S., Venkatkumar, G., Saravanan, M., MubarakAli, D., 2015.
629
Tribulus terrestris Leaf Mediated Biosynthesis of Stable Antibacterial Silver
630
Nanoparticles. Pharmaceutical Nanotechnology. 3, 26-34.
631
Gowramma, B., Keerthi, U., Mokula, R., Rao, D.M., 2015. Biogenic silver nanoparticles
632
production and characterization from native stain of Corynebacterium species and its
633
antimicrobial activity. 3 Biotech. 5, 195-201.
634 635
Hanafy, N.A., Leporatti, S.; El-Kemary, M.A. Mucoadhesive Hydrogel Nanoparticles as Smart Biomedical Drug Delivery System. Appl. Sci. 2019, 9, 825.
636
Hemanth Kumar, N.K., Andia, J.D., Manjunatha, S., Murali, M., Amruthesh, K.N., Jagannath,
637
S., 2019. Antimitotic and DNA-binding potential of biosynthesized ZnO-NPs from leaf
638
extract of Justicia wynaadensis (Nees) Heyne - A medicinal herb. Biocatal. Agric.
639
Biotechnol. 18:101024.
640 641 642
Husseiny, M.I., El-Aziz, M.A., Badr, Y., Mahmoud, M.A., 2007. Biosynthesis of gold nanoparticles using Pseudomonas aeruginosa. Spectrochim. Acta. A. 67, 1003-1006. Ikäheimo, R.; Siitonen, A, Heiskanen, T., Kärkkäinen, U., Kuosmanen, P., Lipponen,
643
P., Mäkelä, P. H., 1996. Recurrence of urinary tract infection in a primary care setting:
644
Analysis of a 1-year follow-up of 179 women. Clin. Infect. Dis. 22, 91-99.
645 646
Iravani, S., 2011. Green synthesis of metal nanoparticles using plants. Green. Chem. 13, 26382650.
647
Jacob, S., Finub, J., Narayanan, A., 2011. Synthesis of silver nanoparticles using Piper longum
648
leaf extracts and its cytotoxic activity against Hep-2 cell line. Colloids. Surf. B.
649
Biointerfaces. 91:212-214.
28
650
Jaggessar, A., Yarlagadda, P. K. D.V., 2020. Modelling the growth of hydrothermally
651
synthesised bactericidal nanostructures, as a function of processing conditions. Mat. Sci.
652
Eng. C 108, Article 110434. https://doi.org/10.1016/j.msec.2019.110434.
653
Jagtap, U., Bapat, V. A., 2013. Green synthesis of silver nanoparticles using Artocarpus
654
heterophyllus Lam. seed extract and its antibacterial activity. Ind. Crops Prod. 46, 132-
655
137.
656
Jamdagni, P., Khatri, P., Rana, J.S., 2018. Green synthesis of zinc oxide nanoparticles using
657
flower extract of Nyctanthes arbor-tristis and their antifungal activity. J. King. Saud.
658
Univ. Sci. 30 (2), 168-175.
659
Jayaseelan, C., Rahuman, A. A., Rajakumar, G., Vishnu Kirthi, A., Santhoshkumar, T.,
660
Marimuthu, S., Bagavan, A., Kamaraj, C., Zahir, A.A., Abdul A., Elango, G., 2011.
661
Synthesis of pediculocidal and larvicidal silver nanoparticles by leaf extract from
662
heartleaf moonseed plant, Tinospora cordifolia Miers. Parasit. Res. 109(1), 185-194.
663 664 665
Jeyabalan, A., Lain, K.Y., 2007. Anatomic and functional changes of the upper urinary tract during pregnancy. Urol. Clin. North. Am., 34, 1-6. Jeyaraj, M., Rajesh, M., Arun, R., MubarakAli, D., Sathishkumar, G., Sivanandhan, G., Dev G.
666
K., Manickavasagam, M., Premkumar, K., Thajuddin, N., Ganapathi, A., 2013. An
667
investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically
668
synthesized silver nanoparticles using Podophyllum hexandrum on human cervical
669
carcinoma cells. Colloids. Surfaces. B. Biointerfaces. 102, 708-717.
670 671 672 673
Jha, A.K., Prasad, K., 2010. Green synthesis of silver nanoparticles using Cycas Leaf. Int. J. Green. Nanotechnol. 1, 110-117. Jha, A.K., Prasad, K., Kulkarni, A.R., 2009. Plant system: Nature’s nanofactory. Colloids. Surf. B. 73, 219-223.
674
Kang, C., Kim J., Park D. W., et al. 2018. Clinical Practice Guidelines for the Antibiotic
675
Treatment of Community-Acquired Urinary Tract Infections. Infection &
676
Chemotherapy. 50(1):67-100. 29
677
Karthikeyan, A. P., Kadarkarai, M., Chellasamy, P., Sekar, P., Jiang-Shiou, H., Marcello, N.,
678
2012. Biolarvicidal and pupicidal potential of silver nanoparticles synthesized using
679
Euphorbia hirta against Anopheles stephensi Liston (Diptera: Culicidae). Parasitol. Res.
680
111, 997-1006.
681
Kassaee, M.Z., Akhavan, A., Sheikh, N., Sodagar, A., 2008. Antibacterial effects of a new dental
682
acrylic resin containing silver nanoparticles. J. Appl. Polym. Sci. 110:1699-1703.
683
Kathiresan, K., Manivannan, S., Nabeel, M.A., Dhivya, B., 2009. Studies on silver nanoparticles
684
synthesized by a marine fungus, Penicillium fellutanum isolated from coastal mangrove
685
sediment. Colloids. Surf. B. 71, 133-137.
686
Khalil, M.M.H., Ismail, E. H., El-Baghdady, K. Z., Mohamed, D., 2014. Green synthesis of
687
silver nanoparticles using olive leaf extract and its antibacterial activity. Arabian J.
688
Chem. 7, 1131-1139.
689 690 691 692 693 694
Khandel, P., Shahi, S.K., 2018. Mycogenic nanoparticles and their bio-prospective applications: current status and future challenges. J. Nanostruct. Chem. 8, 369-91. Khatami, M., Alijani, H.Q., Nejad, M.S., Varma, R.S., 2018. Core@shell Nanoparticles: Greener Synthesis Using Natural Plant Products. Appl. Sci. 8(3), 411. Kim, D., Jeong, S., Moon, J., 2006. Synthesis of silver nanoparticles using the polyol process and the influence of precursor injection. Nanotechnology. 17, 4019-4024.
695
Korbekandi, H., Mohseni, S., Mardani, J.R., Pourhossein, M., Iravani, S., 2016. Biosynthesis of
696
silver nanoparticles using Saccharomyces cerevisiae. Artif. Cells. Nanomed. Biotechnol.
697
44: 235-9.
698
Kowshik, M., Arhtaputre, S., Kharrazi, S., Vogel, W., Urban, J., Kulkarni, S.K., Paknikar, K.M.,
699
2003. Extracellular synthesis of silver nanoparticles by a silver-tolerant yeast strain
700
MKY3. Nanotechnology. 14, 95-100.
701
Krishnamoorthy, P., Jayalakshmi, T., 2012. Preparation, characterization and synthesis of silver
702
nanoparticles by using Phyllanthus niruri for the antimicrobial activity and cytotoxic
703
effects. J. Chem. Pharm. Res. 4 (11), 4783-4794. 30
704
Krishnaraj, C., Jagan, E.G., Rajasekar, S., Selvakumar, P, Kalaichelvan, P.T., Mohan, N., 2010.
705
Synthesis of silver nanoparticles using Acalypha indica leaf extracts and its antibacterial
706
activity against water borne pathogens. Colloids. Surf. B. Biointerfaces. 76(1), 50-56.
707 708 709
Lara, H.H., Ayala-Nuñez, N.V., Ixtepan-Turrent, L., Rodriguez-Padilla, C., 2010. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnol. 8, 1-10. Lee, D.S., Lee S.J., Choe H.S., 2018. Community-Acquired Urinary Tract Infection by
710
Escherichia coli in the Era of Antibiotic Resistance. BioMed Res. Int. 7656752. doi:
711
10.1155/2018/7656752.
712 713 714 715 716
Lee, S.W., Mao, C., Flynn, C., Belcher, A.M., 2002. Ordering of quantum dots using genetically engineered viruses. Science. 296, 892-895. Lok, C.N., Ho. C.M., Chen, R. et al., 2006. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res. 5(4), 916-924. Lotfi, M., Vosoughhosseini, S., Ranjkesh, B., Khani, S., Saghiri, M., Zand, V., 2011.
717
Antimicrobial efficacy of nanosilver, sodium hypochlorite and chlorhexidine gluconate
718
against Enterococcus faecalis. Afr. J. Biotech. 10(35), 6799-6803.
719 720 721
Lu, L., Sun, R.W., Chen, R., Hui, C.K., Ho, C.M., Luk, J.M., Lau, G.K., Che, C.M., 2008. Silver nanoparticles inhibit hepatitis B virus replication. Antivir. Ther. 13, 253-262. Mahendran, V., Gurusamy, A., 2013. Coleus aromaticus leaf extract mediated synthesis of
722
silver nanoparticles and its bactericidal activity. Appl. Nanosci. 3, 217-223.
723
Malik, M. A., Wani, M. Y., Hashim, M. A., 2012. Microemulsion method: a novel route to
724
synthesize organic and inorganic nanomaterials. Arab. J. Chem. 5, 397-417.
725
Mallikarjuna, K., Narasimha, G., Dillip, G. R., Praveen, B., Shreedhar, B., Sree Lakshmi, C.,
726
Reddy, B.V. S., , Raju, B. D. P., 2011. Green synthesis of silver nanoparticles using
727
Ocimum leaf extract and their characterization. Digest J. Nanomat. Biostructures. 6 (1),
728
181-186.
31
729
Manikandan, V., Velmurugan, P., Park, J.H., Chang, W.S., Park, Y.J., Jayanthi, P., Cho, M., Oh,
730
B.T., 2017. Green synthesis of silver oxide nanoparticles and its antibacterial activity
731
against dental pathogens. 3 Biotech 7(1), 72. doi: 10.1007/s13205-017-0670-4.
732
Menon, S., Shrudhi Devi, K.S., Santhiya, R., Rajeshkumar, S., Kumar, V., 2018. Selenium
733
nanoparticles: A potent chemotherapeutic agent and an elucidation of its
734
mechanism. Colloids. Surf. B. Biointerfaces. 170, 280-292.
735 736 737
Mittal, A.K., Chisti, Y., Banerjee, U.C., 2013. Synthesis of metallic nanoparticles using plants. Biotechnol. Adv. 31, 346-356. Moghaddam, A.B., Namvar, F., Moniri, M., Tahir, P.M., Azizi, S., Mohamad, R., 2015.
738
Nanoparticles biosynthesized by fungi and yeast: a review of their preparation,
739
properties, and medical applications. Molecules. 20:16540-16565.
740
Mousavi, B., Tafvizi, F., Bostanabad, S. Z., 2018. Green synthesis of silver nanoparticles using
741
Artemisia turcomanica leaf extract and the study of anti-cancer effect and apoptosis
742
induction on gastric cancer cell line (AGS), Artificial Cells. Nanomed. Biotech. 46(1)
743
499-510, DOI: 10.1080/21691401.2018.1430697.
744
MubarakAli, D., Thajuddin, N., Jeganathan, K., Gunasekaran, M., 2011. Plant extract mediated
745
synthesis of silver and gold nanoparticles and its antibacterial activity against clinically
746
isolated pathogens. Colloids. Surfaces. B. Biointerfaces. 85, 360-365.
747
Muhammad Mailafiya, M., Abubakar, K., Danmaigoro, A., Musa Chiroma, S., Bin Abdul
748
Rahim, E., Aris Mohd Moklas, M., Abu Bakar Zakaria, Z., 2019. Cockle Shell-Derived
749
Calcium Carbonate (Aragonite) Nanoparticles: A Dynamite to Nanomedicine. Appl.
750
Sci. 9, 2897.
751
Murugan, K., Benelli, G., Panneerselvam, C., Subramaniam, J., Jeyalalitha, T., Dinesh, D.,
752
Nicoletti, M., Hwang, J.S., Suresh, U., Madhiyazhagan, P., 2015. Cymbopogon citratus
753
synthesized gold nanoparticles boost the predation efficiency of copepod Mesocyclops
754
aspericornis against malaria and dengue mosquitoes, Exp. Parasitol. 1053, 129-138.
32
755 756 757
Muthu, K., Rangasamy, R., 2013. Green synthesis of silver nanoparticles using Ixora coccinea leaves extract. Material Letters. 97, 141-143. Nagajyothi, P.C., Muthuraman, P., Sreekanth, T.V.M., Kim, D.H., Shim, J., 2017. Green
758
synthesis: In-vitro anticancer activity of copper oxide nanoparticles against human
759
cervical carcinoma cells. Arabian. J. Chem. 10, 215-225.
760 761 762 763 764
Nam, K.Y., 2011. In vitro antimicrobial effect of the tissue conditioner containing silver nanoparticles. J. Adv. Prosthodontics. 3(1), 20-24. Narayanan, K.B., Sakthivel, N., 2010. Biological synthesis of metal nanoparticles by microbes. Adv. Colloid. Interface. Sci. 156, 1-13. Nayak, B. K., Nanda, A., Prabhakar, V., 2018. Biogenic synthesis of silver nanoparticle from
765
wasp nest soil fungus, Penicillium italicum and its analysis against multi drug resistance
766
pathogens. Biocatal. Agric. Biotechnol. 16, 412-418. doi: 10.1016/j.bcab.2018.09.014.
767
Nikalje, A. P., 2015. Nanotechnology and its Applications in Medicine. Med. chem. 5, 81-89.
768
Owens, G.J., Singh, R.K., Foroutan, F., Alqaysi, M, Han, C.M., Mahapatra, C.,Kim, H.W.,
769
Knowles J.C., 2016. Sol–gel based materials for biomedical applications, Prog. Mater.
770
Sci. 77, 1-79, https://doi.org/10.1016/j.pmatsci.2015.12.001.
771 772 773
Pal, D., Sahu, C.K., Haldar, A., 2014 Bhasma : The ancient Indian nanomedicine. J. Adv. Pharm. Technol. Res. 5(1), 4-12. Panneerselvam, C., Murugan, K., Amerasan, D., 2015. Biosynthesis of Silver Nanoparticles
774
Using Plant Extract and its Anti-Plasmodial Property. Adv. Materials. Res., 1086, 11-30.
775
Panneerselvam, C., Ponarulselvam, S., Murugan, K., 2011 Potential Anti-plasmodial Activity of
776
Synthesized Silver Nanoparticle using Andrographis paniculata Nees (Acanthaceae).
777
Arch. Appl. Sci. Res., 3(6):208-217.
778
Parida, U.K., Bindhani, B.K., Nayak, P., 2011. Green synthesis and characterization of gold
779
nanoparticles using onion (Allium cepa) extract. World. J. Nano. Sci. Eng. 1, 93-98.
33
780
Patil, S.V., Borase, H.P., Patil, C.D., Salunke, B.K., 2012. Biosynthesis of silver nanoparticles
781
using latex from few Euphorbian plants and their antimicrobial potential. Appl. Biochem.
782
Biotechnol. 167(4), 776-790.
783 784 785 786 787 788 789
Pazhayattil, G.S., Shirali, A.C., 2014. Drug-induced impairment of renal function. Int. J. Nephrol. Renovasc. Dis. 7,457-468. Philip, D., 2009. Biosynthesis of Au, Ag and Au-Ag nanoparticles using edible mushroom extract. Spectrochim. Acta. A. 73, 374-381. Philip, D., 2010. Green synthesis of gold and silver nanoparticles using Hibiscus rosa sinensis. Phys. E. 42, 1417-1424. Ponarulselvam, S., Panneerselvam, C., Murugan, K., Aarthi, N., Kalimuthu,
790
K., Thangamani, S., 2012. Synthesis of silver nanoparticles using leaves of Catharanthus
791
roseus Linn. G. Don and their antiplasmodial activities. Asian. Pac. J. Trop. Biomed.
792
2(7), 574-580.
793
Prabhu, K., Murugan, K., Nareshkumar, A., Ramasubramanian, N., Bragadeeswaran, S. 2011.
794
Larvicidal and repellent potential of Moringa oleifera against malarial vector, Anopheles
795
stephensi Liston (Insecta: Diptera: Culicidae). Asian. Pac. J. Trop. Biomed. 1 (2), 124-
796
129.
797
Premkumar, J., Sudhakar, T., Dhakal, A., Shrestha, J.B., Krishnakumar, S., Balashanmugam, P.
798
2018. Synthesis of silver nanoparticles (AgNPs) from cinnamon against bacterial
799
pathogens. Biocatal. Agric. Biotechnol. 15, 311-316.
800
Priyadarshini, S., Mainal, A., · Sonsudin, F., Yahya, R., .Abdullah, Alyousef, A.A.,
801
Mohammed, A., 2019. Biosynthesis of TiO2 nanoparticles and their superior
802
antibacterial effect against human nosocomial bacterial pathogens. Res. Chem.
803
Intermediates. https://doi.org/10.1007/s11164-019-03857-6.
804 805
Priyadarsini, S., Mukherjee, S., Mishra, M., Nanoparticles used in dentistry: A review. 2018. J. Oral. Biol. Craniofac. Res. 8, 58-67.
34
806
Radovic-Moreno, A. F., , Lu, T. K., Puscasu, V. A., Yoon, C. J., Langer, R., Farokhzad, O.C.,
807
2012. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted
808
delivery of antibiotics. ACS. Nano. 6, 4279-4287.
809 810
Rai, M., Yadav, A., Gade, A., 2009. Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 27(1), 76-83.
811
Rajakumar, G., Rahuman, A., 2011. Larvicidal activity of synthesized silver nanoparticles using
812
Eclipta prostrata leaf extract against filariasis and malaria vectors. Acta Tropica.
813
118,196-203. 10.1016/j.actatropica.2011.03.003.
814
Rajeshkumar, S., Bharath, L.V., 2017. Mechanism of plant-mediated synthesis of silver
815
nanoparticles – A review on biomolecules involved, characterisation and antibacterial
816
activity, Chemico-Biol. Interactions. doi: 10.1016/j.cbi.2017.06.019.
817
Ramesh, M., Anbuvannan, M., Viruthagiri, G., 2015 Green synthesis of ZnO nanoparticles using
818
Solanum nigrum leaf extract and their antibacterial activity. Spectrochim. Acta. A Mol.
819
Biomol. Spectrosc. 136, 864-870.
820
Rane, A., Kanny, K., Abitha, V.K., Thomas, Sabu. Methods for Synthesis of Nanoparticles and
821
Fabrication of Nanocomposites. In: Synthesis of inorganic nanoparticle. Elsevier Ltd.,
822
Amsterdam, 2018, pp 121-139. 10.1016/B978-0-08-101975-7.00005-1.
823
Ravikumar, S., Gokulakrishnan, R., Boomi, P., 2012. In vitro antibacterial activity of the metal
824
oxide nanoparticles against urinary tract infections bacterial pathogens. Asian. Pacific. J.
825
Trop. Dis. 2:85-89.
826
Rogers, J.V., Parkinson, C.V., Choi, Y.W., Speshock, J.L., Hussain, S.M., 2008. A preliminary
827
assessment of silver nanoparticles inhibition of monkeypox virus plaque formation.
828
Nanoscale Res. Lett. 3, 129-133.
829
Roh, Y., Lauf, R.J., McMillan, A.D., Zhang, C., Rawn, C.J., Bai, J., Phelps, T.J., 2001.
830
Microbial synthesis and the characterization of metal-substituted magnetites. Solid State
831
Commun. 118, 529-534.
35
832
Roy, A., Bulut, O., Some, S., Mandal, A.K., Yilmaz, M.D., 2019. Green synthesis of silver
833
nanoparticles: Biomolecule-nanoparticle organizations targeting antimicrobial activity.
834
RSC. Adv. 9, 2673-2702.
835
Samiei, M., Aghazadeh, M., Lotfi, M., Shakoei, S., Aghazadeh, Z., Pakdel, S. M. V., 2013.
836
Antimicrobial efficacy of mineral trioxide aggregate with and without silver
837
nanoparticles. Iranian. Endodontic. J. 8(4)166-170.
838
Sangeetha, G. Rajeshwari, S., Rajendran, V., 2011. Green synthesis of zinc oxide nanoparticles
839
by Aloe barbadensis miller leaf extract: Structure and optical properties. Mat. Res. Bull..
840
46, 2560-2566.
841
Santhoshkumar, J., Kumar, S.V., Rajeshkumar, S., 2017. Synthesis of zinc oxide nanoparticles
842
using plant leaf extract against urinary tract infection pathogen. Resource-Efficient.
843
Technol. http://dx.doi.org/10.1016/j.reffit.2017.05.001.
844
Santhoshkumar, T., Rahuman, A. A., Rajakumar, G., Marimuthu, S., Bagavan, A.;,Jayaseelan,
845
C., Zahir, A.A. Gandhi, E., Kamaraj, C., 2011. Synthesis of silver nanoparticles using
846
Nelumbo nucifera leaf extract and its larvicidal activity against malaria and filariasis
847
vectors. Parasit. Res. 108(3), 693-702.
848
Sarkar, S., Kotteeswaran, V., 2018. Green synthesis of silver nanoparticles from aqueous leaf
849
extract of Pomegranate (Punica granatum) and their anticancer activity on human
850
cervical cancer cells. Adv. Nat. Sci: Nanosci. Nanotechnol. 9025014.
851
Scherrer, P., 2018. Bestimmung der Groβe und der inneren struktur von kolloidteilichen mittels
852
Rontgenstrahlen, nachrichten von der von der Gesellschaft der Wissenchaften zu
853
Gottingen. Mathmatisch- physikalische Klasse. 98-100.
854 855 856 857
Schmalz, G., Arenholt-Bindslev D., 2009. Biocompatibility of dental materials. Springer Verlag, Berlin, Heidelberg, pp. 2-3, 71-72. Shah, M., Fawcett, D., Sharma, S., Tripathy, S.K., Poinern, G.E.J., 2015. Green synthesis of metallic nanoparticles via biological entities. Materials. 8, 7278-7308.
36
858 859
Sharma, R., Prajapati, P.K., 2016. Nanotechnology in medicine: Leads from Ayurveda. J. Pharm. Bioallied Sci. 8, 80-81.
860
Sharma, V., Kaushik, S., Pandit, P., Dhull, D., Yadav, J.P., Kaushik, S., 2019. Green synthesis of
861
silver nanoparticles from medicinal plants and evaluation of their antiviral potential
862
against chikungunya virus. Appl. Microbiol. Biotechnol. 103:881-891.
863
Shi, J., Xiao, Z., Kamaly, N., Farokhzad, O.C., 2011. Self-assembled targeted nanoparticles:
864
evolution of technologies and bench to bedside translation. Acc. Chem. Res. 44:1123-
865
1134.
866
Singh, A., Jain, D., Upadhyay M. K., Khandelwal, N., Verma, H. N., 2010.Green synthesis of
867
silver Nanoparticles Using Argemone mexicana leaf extract and evaluation of their
868
antimicrobial activities. Digest J. Nanomat. Biostr. 5(2), 483-489.
869
Sivaraj R, Rahman, P.K., Rajiv, P., Salam, H.A., Venckatesh, R., 2014. Biogenic copper oxide
870
nanoparticles synthesis using Tabernaemontana divaricate leaf extract and its
871
antibacterial activity against urinary tract pathogen, Spectrochim. Acta. Part A: Mol.
872
Biomol. Spectrosc. 133:178-181.
873 874 875 876 877
Soni, N., Prakash, S., 2012. Synthesis of gold nanoparticles by the fungus Aspergillus niger and its efficacy against mosquito larvae. Rep. Parasitol. 2, 1-7. Soni, N., Prakash, S., 2014. Green nanoparticles for mosquito control, Sci. Worl J. 6 http://dx.doi.org/10.1155/2014/496362. Srinivas, M. A., Chandrashekar, U. K., Shivashankara, K. N., Pruthvi, B. C., 2014 Clinical
878
profile of urinary tract infections in diabetics and non-diabetic. Australasian. Med. J.
879
7(1), 29-34.
880
Srivastava, J., Chandra, H., Nautiyal, A.R., Kalra, S.S., 2014 Antimicrobial resistance (AMR)
881
and plant-derived antimicrobials (PDAms) as an alternative drug line to control
882
infections. 3 Biotech. 4, 451-460.
37
883
Suganya, K.S., Govindaraju, K., Kumar, V.G., Dhas, T.S., Karthick, V., Singaravelu, G.,
884
Elanchezhiyan, M., 2015. Blue green alga mediated synthesis of gold nanoparticles and
885
its antibacterial efficacy against gram positive organisms. Mat. Sci. Eng. C 47,351-356.
886 887 888 889 890
Suk, J.S., Xu, Q., Kim, N., Hanes, J., Ensign, L.M., 2016. PEGylation as a strategy for improving nanoparticle‐based drug and gene delivery. Adv. Drug. Deliv. Rev. 99:28-51. Sukanya, M.K., Saju, K.A., Praseetha, P.K., Sakthivel, G., 2013. Therapeutic potential of biologically reduced silver nanoparticles from Actinomycete cultures. J. Nanosci. 1-8. Sukirtha, R., Priyanka, K.M., Antony, J.J., Kamalakkannan, S., Ramar, T., Palani, G., 2011.
891
Cytotoxic effect of green synthesized silver nanoparticles using Melia azedarach against
892
in vitro HeLa cell lines and lymphoma mice model. Process. Biochem. 47, 273-279.
893
Sun, R.W., Chen, R., Chung, N.P., Ho, C.M., Lin, C.L., Che, C.M., 2005. Silver nanoparticles
894
fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells.
895
Chem.Commun. (Camb) 40, 5059-5061.
896
Sundararajan, B., Kumari, B.R., 2017. Novel synthesis of gold nanoparticles using Artemisia
897
vulgaris L. leaf extract and their efficacy of larvicidal activity against dengue fever
898
vector Aedes aegypti L. J. Trace. Elem. Med. Biol. 43:187-196.
899
Sunkar, S., Nachiyar, C.V., 2012. Biogenesis of antibacterial silver nanoparticles using the
900
endophytic bacterium Bacillus cereus isolated from Garcinia xanthochymu. Asian. Pac. J.
901
Trop. Biomed. 12, 953-959.
902
Suriyaraj, S.P., Ramadoss, G., Chandraraj, K., Selvakumar, R., 2019. One pot facile green
903
synthesis of crystalline bio-ZrO2 nanoparticles using Acinetobacter sp. KCSI1 under
904
room temperature.105,110021, Mat.Sci.Eng.C,
905
https://doi.org/10.1016/j.msec.2019.110021.
906 907
Thiagarajan, S., Sanmugam, A., Vikraman, D., 2017. Facile Methodology of Sol-Gel Synthesis for Metal Oxide Nanostructures. Recent. Appl. Sol-Gel Synth. 1-16.
38
908
Veerakumar, K., Govindarajan, M., Rajeswary, M., Muthukumaran, U., 2014. Low-cost and eco-
909
friendly green synthesis of silver nanoparticles using Feronia elephantum (Rutaceae)
910
against Culex quinquefasciatus, Anopheles stephensi, and Aedes aegypti (Diptera:
911
Culicidae). Parasitol. Res. 113, 2363-2373.
912
Veerasamy, R., Xin, T. Z., Gunasagaran, S., Wei Xiang, T. F., Chou Yang, E. F., Jeyakumar, N.,
913
Dhanaraj, S. A., 2011. Biosynthesis of silver nanoparticles using mangosteen leaf extract
914
and evaluation of their antimicrobial activities. J. Saudi. Chem. Soc. 15, 113-120.
915
Ventola, C.L., 2015. The antibiotic resistance crisis. Pharmaceutic and Therapeutics 40(4), 277-
916 917
283. Vigneshwaran, N., Ashtaputre, N.M., Varadarajan, P.V., Nachane, R.P., Paralikar, K.M.,
918
Balasubramanya, R.H., 2007. Biological synthesis of silver nanoparticles using the
919
fungus Aspergillus flavus. Mater. Lett. 61, 1413-1418.
920
Vinayak, S., Biswas, S., Dev, V., Kumar, A., Ansari, M. A., Sharma, Y.D., 2003. Prevalence of
921
the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine
922
responders in India. Acta Trop. 87, 287-293.
923 924 925 926 927 928 929 930 931
von Overbeck J, 2003. Insurance and epidemics: SARS, West Nile virus and Nipah virus. J. Insur. Med. 35, 165-173. Wagner, V., Dullaart, A., Bock, A.K., Zweck, A., 2006. The emerging nanomedicine landscape. Nat Biotechnol 24:1211-1217. Wang, Z., Colombi Ciacchi, L., Wei, G., 2017. Recent Advances in the Synthesis of GrapheneBased Nanomaterials for Controlled Drug Delivery. Appl. Sci. 7, 1175. Yamamoto, K., Ohashi, S., Aono, M., Kokubo, T., Yamada, I., Yamauchi, J., 1996. Antibacterial activity of silver ions implanted in SiO2 filler on oral streptococci. Dent. Mater. 12, 227. Yong, P., Rowsen, N.A., Farr, J.P.G., Harris, I.R., Macaskie, L.E., 2002. Bioreduction and
932
biocrystallization of palladium by Desulfovibrio desulfuricans NCIMB 8307. Biotechnol.
933
Bioeng. 80, 369-379.
39
934
Zargar, M., Hamid, A. A., Bakar, F.A, Shamsudin, M.N, Shameli, K., Jahanshiri, F., Farahani,
935
F., 2011. Green synthesis and antibacterial effect of silver nanoparticles using Vitex
936
negundo L. Molecules. 16(8), 6667-6676.
937 938 939
Zayed, M.F., Eisa, W.H., Shabaka, A. A., 2012. Malva parviflora extract assisted green synthesis of silver nanoparticles. Spectrochim. Acta. A. Mol. Biomol. Spectroscopy. 98:423-428. Zhao, L., Wang, H., Huo, K., Cui, L., Zhang, W., Ni, H., Zhang, Y., Wu, Z., Chu, P.K., 2011.
940
Antibacterial nano-structured titania coating incorporated with silver nanoparticles.
941
Biomaterials. 32(24), 5706-5716.
942
40
S.No
Medicinal Plant
1. 2. 3. 4.
Syzygium cumini Ixora coccinea Ananas comosus L. Memecylon umbellatum Malva parviflora
5.
6. 7. 8. 9. 10. 11. 12. 13. 14. 15.
Jatropha curcas Jatropha gossypifolia Pedilanthus tithymaloides Euphorbia milii Vitex Negundo Artocarpus heterophyllus Euphorbia hirta Coleus aromaticus Cycas Iresine herbstii
16. Melia azedarach 17. Eclipta prostrata 18. Tinospora cordifolia Miers 19. Boswellia ovalifoliolata 20. Andrographis paniculata 21. Nelumbo nucifera
Types of Nanoparticles (NPs) AgNP AgNP AgNP AgNP
Plant part used Seed Leaves Fruit Leaf
Size of NPs (in nm) 93 13-57 12 15-20
AgNps
Leaf
19-25
AgNP AgNP AgNP
Latex Latex Latex
73 62 123
AgNP AgNP AgNP
Latex Leaf Seed
AgNP AgNP AgNP AgNP
Medicinal Properties
References
Antioxidant activity ND Antioxidant activity Antimicrobial activity
Banerjee and Narendhirakannan, (2011) Muthu and Rangasamy, (2013) Ahmed and Sharma (2012) Arunachalam et al., 2013
Inflammation, abscesses, pimples, kidney infections, vaginal inflammation, fever, headache, spider stings, bronchitis, pharingitis, tuberculosis Antibacterial Antibacterial Antibacterial
Zayed et al., 2012
105 18.2 10.78
Antibacterial Antibacterial Antibacterial
Patil et al., 2012 Zargar et al., 2011 Jagtap and Bapat (2013)
Leaf Leaf Leaf Leaf
20-30 40-50 2-6 44-64
Karthikeyan et al. (2012) Mahendran and Gurusamy (2013) Jha and Prasad (2013) Dipankar and Murigun (2012)
AgNP AgNP AgNP
Leaf Leaf Leaf
78 35-65 55-80
Larvicidal and Pupicidal Bactericidal Antioxidant Antioxidant, Antimicrobial and antitumor activity Antitumor activity Larvicidal activity Pediculocidal and Larvicidal
AgNP
Stem
30-40
Rheumatic pains
Ankanna et al. (2010)
AgNP
Leaf
35-55
Anti-plasmodial Activity
Panneerselvam et al. (2011)
AgNP
Leaf
45
Larvicidal activity against
Santhoshkumar et al., 2011
Patil et al., 2012 Patil et al., 2012 Patil et al., 2012
Sukirtha et al. (2012) Rajakumar and Rahuman (2011) Jayaseelan et al. (2011)
22. Ocimum
AgNP
Leaf
3-20
Stem, Root 23. 24. 25. 26.
malaria and filariasis vectors Treatment of headaches, coughs, diarrhea, constipation, worms and kidney malfunctions
Mallikarjuna et al. (2011)
Catharanthus roseus Azadirachta indica Olive Hibiscus rosa sinensis 27. Aloe vera 28. Acalypha indica
AgNP AgNP AgNP AgNP
Leaf Leaf Leaf Leaf
35-55 43 20-25 5000
Antiplasmodial activity Antimicrobial Antibacterial Fish pathogen A. hydrophila
Ponarulselvam et al. (2012) Gavhane et al. (2012) Khalil et al. (2014) Philip (2010)
AgNP AgNP
Leaf Leaf
70-192 20-30
Chandran et al. 2006 Krishnaraj et al., 2010
29. Garcinia mangostana 30. Phyllanthus niruri
AgNP
Leaf
35
Antibacterial Antibacterial against fish pathogens MDR Human pathogens
AgNP
Leaf
32-53
Antimicrobial and cytotoxic effect
Krishnamoorthy and Jayalakshmi (2012)
31. Argemone Mexicana 32. Hibiscus subdariffa
AgNP ZnONPs
Leaf Leaf
20 12-46
33. Aloe barbadensis miller ZnONPs
Leaf
25-40
34. Trifolium pratense
ZnONPs 35. Nyctanthes arbor-tristis ZnONPs
Flower
Veerasamy et al., 2011
Antimicrobial Singh et al. (2010) Antibacterial and Antidiabetic Bala et al. (2015) Sangeetha et al. (2011) Cosmetics
100-190 Antibacterial
Dobrucka and Długaszewska, ( 2016)
Flower
12-32
Antifungal
Jamdagni et al. (2018)
36. Solanum nigrum
ZnONPs
Leaf
29.79
Antibacterial
Ramesh et al. (2015)
37. Azadirachta indica
ZnONPs
Leaf
18
Antimicrobial
Elumalai and Velmurugan (2015)
38. Passiflora caerulea
ZnONPs
Leaf
37.67
Antibacterial
Santhoshkumar, et al. (2017)
39. Murraya koenigii
ZnONPs
Leaf
30-35
Antimicrobial
Divyapriya et al. (2014)
40. Hibiscus subdariffa
ZnONPs
Leaf
16-60
Antibacterial and Antidiabetic Bala et al. (2015)
41. Berberis aristata
ZnO NPs
Roots
20-40
Urinary tract pathogens
Chandra et al. (2019)
Highlights • • • •
Green synthesis involves eco-friendly, less toxic methods exploiting medicinal and aromatic plants etc. Biosynthesized metallic nanoparticles have shown potential role as antibacterial agents. The nanoparticles are considered as potential antioxidants and promising candidates in cancer treatment. They will open new avenues in Biomedical applications like antiparasitic, dentistry, urinary tract infections etc.